By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Mary Jane's PostMary Jane's Post
  • Tech
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Us
    • Advertise
    • Monthly Give-Away
    • Partner With Us
  • Join UsNew
Reading: cbdMD Announces Research Partnership with the University of Mississippi, to Identify Novel Cannabinoids
Share
0

No products in the cart.

Aa
Aa
Mary Jane's PostMary Jane's Post
0
  • Cannabis Press Releases
  • Submit News
  • Join UsNew
Search
  • Topics
    • Business
    • Cannabis Community
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Us
    • Guest Columnist
    • Ambassador
    • Partner With Us
Have an existing account? Sign In
Follow US
©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.
Mary Jane's Post > Cannabis Press Releases > cbdMD Announces Research Partnership with the University of Mississippi, to Identify Novel Cannabinoids
Cannabis Press Releases

cbdMD Announces Research Partnership with the University of Mississippi, to Identify Novel Cannabinoids

Business Wire
Posted Business Wire October 7, 2021
Updated 2021/10/07 at 1:45 PM
3 Min Read
SHARE

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD companies, announced October 7 that cbdMD Therapeutics, its newly formed research division, has finalized a research partnership with the University of Mississippi (UM) and its National Center for Natural Products Research (NCNPR). UM is considered one of the leading cannabinoid research institutes in the United States. The research partnership aims to identify novel cannabinoids to be patented for therapeutic use in accordance with the U.S. and other governments regulatory standards. The studies will commence at the university in Fall 2021.

cbdmd logo color Cannabis News

The project’s major emphasis is to explore the chemistry and biology of minor cannabinoids beyond cannabidiol (CBD). The new cannabinoids will be evaluated for their receptor activity and the most promising will be studied for their safety and efficacy.

“This work raises the bar for the entire cannabinoid industry. We are breaking new ground with the identification of novel cannabinoids and the exploration of their benefits for our consumers,” said Dr. Sibyl Swift, Vice President of Scientific and Regulatory Affairs at cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the “SEC”) on December 22, 2020 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1 THC-free means below the level of detection using validated scientific methods.

Cannabis News

Contacts

PR:

Robert Pettway

Director of Public Relations

[email protected]
423-503-5225

Investors:

John Weston

Director of Investor Relations

[email protected]
704-249-9515

You Might Also Like

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer

AltaSea, CSUN, LA Coalition, and Santa Monica College to Hold Second Annual Webinar Series Focused on Aquaculture for the Economy and Ecosystem

Employees at New Jersey’s Largest Smoke Shop Chain Submit Landmark Petition in Favor of Unionizing to National Labor Relations Board

Applied UV Declares Monthly Preferred Stock Dividend

Nabis Reports Steady YoY Growth, Becomes No. 1 Licensed Cannabis Wholesale Platform in California

TAGGED: Business Wire
Business Wire October 7, 2021
Share this Article
Facebook Twitter Pinterest LinkedIn Reddit
Share
Business Wire
Posted by Business Wire
Follow:
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.
Previous Article Eaze Executive Jennifer Lujan Joins Board of National Hispanic Cannabis Council
Next Article International Medical Cannabis Company Directory 2021 – ResearchAndMarkets.com
- Advertisement -
Ad imageAd image

Stay Connected

Facebook Like
Twitter Follow
Pinterest Pin
Instagram Follow

You Might Also Like

Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer

May 24, 2022

AltaSea, CSUN, LA Coalition, and Santa Monica College to Hold Second Annual Webinar Series Focused on Aquaculture for the Economy and Ecosystem

May 24, 2022

Employees at New Jersey’s Largest Smoke Shop Chain Submit Landmark Petition in Favor of Unionizing to National Labor Relations Board

May 24, 2022

Applied UV Declares Monthly Preferred Stock Dividend

May 24, 2022
Mary Jane's PostMary Jane's Post

©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.

  • PRIVACY
  • TERMS OF USE
  • CONTRIBUTOR AGREEMENT
  • CONTRIBUTOR GUIDELINES

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Register Lost your password?